Flagship Ventures Fund V, L.P. 13D and 13G filings for Kaleido Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-10 5:15 pm Purchase | 2021-02-08 | 13D | Kaleido Biosciences, Inc. KLDO | Flagship Ventures Fund V, L.P. | 19,575,710 47.700% | 215,000 (+1.11%) | Filing |
| 2020-06-08 4:30 pm Purchase | 2020-06-04 | 13D | Kaleido Biosciences, Inc. KLDO | Flagship Ventures Fund V, L.P. | 19,360,710 55.000% | 2,000,000 (+11.52%) | Filing |